Can fibrinolytic therapy be clinically useful in severe pneumonia caused by COVID-19?

J Thromb Thrombolysis. 2021 Apr;51(3):633-636. doi: 10.1007/s11239-020-02247-9. Epub 2020 Aug 12.
No abstract available

Publication types

  • Review

MeSH terms

  • COVID-19 Drug Treatment*
  • Fibrinolytic Agents / therapeutic use*
  • Humans

Substances

  • Fibrinolytic Agents